2019-08-21 | Purchase | Aquestive Therapeutics, Inc. AQST | | | $3.81 | $6,858 | +7.92% | |
2019-08-20 | Purchase | Aquestive Therapeutics, Inc. AQST | | | $3.80 | $86,001 | +15.08% | |
2019-08-19 | Purchase | Aquestive Therapeutics, Inc. AQST | | | $3.77 | $81,095 | +17.25% | |
2017-09-07 | Purchase | Matinas BioPharma Holdings, Inc. MTNB | director | | $1.29 | $6,450 | -29.01% | |
2017-06-05 | Sale | Pacira BioSciences, Inc. PCRX | President | | $43.32 | $170,338 | -16.72% | |
2017-05-15 | Sale | Pacira BioSciences, Inc. PCRX | President | | $28.34 | $1.13M | -26.76% | |
2017-01-17 | Sale | Pacira BioSciences, Inc. PCRX | President | | $38.53 | $1.54M | +10.19% | |
2016-11-15 | Sale | Pacira BioSciences, Inc. PCRX | President | | $19.05 | $762,200 | +7.05% | |
2016-08-15 | Sale | Pacira BioSciences, Inc. PCRX | President | | $45.21 | $2.26M | -7.91% | |
2015-09-11 | Purchase | Pacira BioSciences, Inc. PCRX | SVP, Chief Financial Officer | | $61.37 | $306,850 | -19.77% | |
2015-02-06 | Sale | Pacira BioSciences, Inc. PCRX | SVP, Chief Financial Officer | | $111.22 | $3.34M | -39.16% | |
2014-11-07 | Sale | Pacira BioSciences, Inc. PCRX | SVP, Chief Financial Officer | | $87.18 | $2.62M | -8.44% | |
2014-08-08 | Sale | Pacira BioSciences, Inc. PCRX | SVP, Chief Financial Officer | | $99.63 | $2.99M | -8.73% | |
2014-05-08 | Sale | Pacira BioSciences, Inc. PCRX | SVP, Chief Financial Officer | | $75.05 | $2.25M | +22.95% | |
2013-12-30 | Sale | Pacira BioSciences, Inc. PCRX | Chief Financial Officer | | $28.58 | $571,600 | +52.48% | |
2013-09-30 | Sale | Pacira BioSciences, Inc. PCRX | Chief Financial Officer | | $24.18 | $483,500 | +49.34% | |
2013-06-28 | Sale | Pacira BioSciences, Inc. PCRX | Chief Financial Officer | | $14.83 | $296,560 | +94.79% | |
2013-03-28 | Sale | Pacira BioSciences, Inc. PCRX | Chief Financial Officer | | $15.05 | $301,000 | +64.43% | |
2011-02-15 | Purchase | Pacira BioSciences, Inc. PCRX | Chief Financial Officer | | $7.04 | $70,400 | +31.04% | |